104 -10 (72) 2024 - Torakulov B.Kh., Shukurdzhanova S.M. - CHRONIC HEART FAILURE AND HEART RHYTHM DISORDERS AFTER 3 AND 6 MONTHS IN THE POST-COVID PERIOD

CHRONIC HEART FAILURE AND HEART RHYTHM DISORDERS AFTER 3 AND 6 MONTHS IN THE POST-COVID PERIOD

Torakulov B.Kh. - Tashkent Medical Academy

Shukurdzhanova S.M. - Tashkent Medical Academy

Torakulova K.Kh. - Tashkent Medical Academy

Resume

Objective: To study the features of the course of CHF, the frequency and nature of cardiac arrhythmias in patients with ischemic heart disease, angina pectoris, complicated by CHF in the postcovid period. Material and methods. 69 patients were studied. All patients underwent conventional examinations, Holter ECG monitoring . The clinical condition of the patients was assessed on the SHOKS scale, the quality of life was assessed according to the Minnesota questionnaire. Results. According to the Holter monitoring ECG data in patients in the postcovid period, rhythm disturbances were most often represented by supraventricular premature beats in 38.7%, premature ventricular contraction in 34.1%, atrial fibrillation in 9.1% of patients. When assessing the clinical state of SHOKS, a significant difference was revealed depending on the history of COVID-19. A more significant decrease in exercise tolerance was observed in patients who underwent COVID-19. There is also a difference in the indicators of the total quality of life index . Conclusions. In patients with coronary heart disease complicated by CHF FC II-III, various disturbances of the rhythm and conduction of the heart are more often observed in postcovid period, there is a more severe clinical condition of patients and lower quality of life indicators.

Keywords: chronic heart failure, postcovid period, cardiac arrhythmia, quality of life

First page

585

Last page

592

For citation:Torakulov B.Kh., Shukurdzhanova S.M., Torakulova K.Kh. - CHRONIC HEART FAILURE AND HEART RHYTHM DISORDERS AFTER 3 AND 6 MONTHS IN THE POST-COVID PERIOD//New Day in Medicine 10(72)2024 585-592 https://newdayworldmedicine.com/en/new_day_medicine/10-72-2024

List of References

1. Arachchillage D.R. J., Laffan M. Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J. Thromb. Haemost. 2020;18(5):1233-4. doi: 10.1111/jth.14820.
2. Eliezer M., Hautefort Ch., Hamel A-L. et al. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19. JAMA. Otolaryngol. Head Neck. Surg. 2020. doi:10.1001/ jamaoto.2020.0832.
3. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. doi:10.1001/jamacardio.2020.1017
4. Hanley B., Lucas S.B., Youd E. et al. Autopsy in suspected COVID-19 cases. J. Clin. Pathol. 2020;73(5):239-42. doi:10.1136/jclinpath-2020–206522.
5. Kogan EA, Berezovskiy YuS, Blagova OV, et al. Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical. Kardiologia. 2020;60(7):4-10. doi:10.18087/cardio.2020.7.n1209.
6. Poteshkina NG, Lysenko MA, Kovalevskaya EA, et al. Cardiac damage in patients with COVID-19 coronavirus infection. “Arterialnaya Gipertenziya” (“Arterial Hypertension”). 2020;26(3):277-87. (In Russ.) doi:10.18705/1607-419X-2020-26-3-277-287/
7. Xu X., Barth R.F., Buja L.M. A call to action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infections. CHEST. 2020. doi: 10.1016/j. chest.2020.03.060.

   file

   download